624 Elexacaftor/tezacaftor/ivacaftor for treatment of cystic fibrosis: Experience in Argentina from October 2021 to March 2022 von Martin, M., Mendez, A., Brown, M., Dziubecki, M., Damnotti, C., Basualdo, S., Nessi, M., Incardona, C.

Volltext

P054 Partial report of the monitoring program of patients with cystic fibrosis in treatment with lucaftor therapy (lumacaftor-ivacaftor) von Mendez, A.C., Darderes, M.G. Garcia, Brown, M.C., Dziubecki, M., Damnotti, C., Incardona, C.

Volltext